Table 2 Preadmission use of calcium channel blockers or beta blockers and 30-day mortality estimates following stroke

Ischemic stroke

 Non-use

10.3 (10.1-10.5)

1 (reference)

1 (reference)

9.8 (9.5-10.0)

1 (reference)

1 (reference)

 Former use

13.1 (11.9-14.3)

1.29 (1.16-1.43)

1.04 (0.94-1.15)

13.0 (11.8-14.2)

1.35 (1.22-1.49)

1.01 (0.91-1.12)

 Current use

12.4 (11.9-13.0)

1.22 (1.15-1.29)

0.99 (0.94-1.05)

13.9 (13.3-14.4)

1.45 (1.38-1.52)

1.01 (0.96-1.07)

  New use

10.1 (9.1-11.1)

0.97 (0.88-1.08)

0.89 (0.80-0.99)

12.6 (11.6-13.6)

1.31 (1.19-1.43)

0.97 (0.88-1.06)

  Long-term use

13.3 (12.6-14.0)

1.31 (1.24-1.39)

1.03 (0.97-1.10)

14.3 (13.7-14.9)

1.50 (1.42-1.58)

1.02 (0.96-1.08)

Intracerebral hemorrhage

 Non-use

34.1 (33.2-35.0)

1 (reference)

1 (reference)

33.3 (32.4-34.3)

1 (reference)

1 (reference)

 Former use

37.5 (32.6-42.9)

1.11 (0.93-1.32)

0.92 (0.77-1.10)

40.6 (35.8-45.8)

1.29 (1.09-1.52)

1.00 (0.84-1.19)

 Current use

41.3 (38.6-44.2)

1.28 (1.16-1.41)

1.05 (0.95-1.16)

41.9 (39.7-44.2)

1.35 (1.25-1.46)

0.95 (0.87-1.04)

  New use

36.6 (31.4-42.5)

1.09 (0.90-1.33)

0.95 (0.78-1.16)

41.7 (37.2-46.6)

1.36 (1.17-1.58)

0.96 (0.81-1.12)

  Long-term use

42.9 (39.7-46.3)

1.35 (1.21-1.50)

1.09 (0.97-1.22)

42.0 (39.5-44.5)

1.35 (1.24-1.47)

0.94 (0.85-1.04)

Subarachnoid hemorrhage

 Non-use

22.6 (21.3-23.9)

1 (reference)

1 (reference)

22.8 (21.6-24.2)

1 (reference)

1 (reference)

 Former use

32.2 (24.4-41.7)

1.51 (1.08-2.11)

1.05 (0.75-1.48)

25.0 (17.4-35.2)

1.12 (0.74-1.69)

0.60 (0.38-0.95)

 Current use

33.0 (28.4-38.0)

1.56 (1.29-1.89)

1.05 (0.85-1.29)

31.6 (27.3-36.3)

1.46 (1.21-1.75)

0.89 (0.72-1.11)

  New use

29.1 (21.0-39.5)

1.38 (0.94-2.02)

0.98 (0.66-1.45)

28.3 (20.5-38.3)

1.24 (0.85-1.81)

0.70 (0.46-1.06)

  Long-term use

34.3 (28.9-40.2)

1.62 (1.31-2.01)

1.06 (0.84-1.34)

32.6 (27.7-38.1)

1.53 (1.25-1.88)

0.92 (0.72-1.17)